糖尿病肾病发病机制研究进展(4)
[16] Schrijvers BF，Flyvbjerg A，De Vriese AS.The role of vascular endothelial growth factor(VEGF) in renal pathophysiology.Kidney Int，2004，65(6)：2003-2017.
[17] 刘志红.胰岛素抵抗在糖尿病肾病发病中的作用.中国实用内科杂志，2002，22(9)：519-521.
[18] Venable ME，Zimmerman GA，McIntyre TM，et al.Platelet-activating factor：a phospholipid autacoid with diverse action.J Lipid Res，1993，34(5)：691-702.
[19] Lenz O，SJ，Stetler-Stevenson WG.Matrix metalloproteinases in renal development and disease.J Am Soc Nephrol，2000，11(3)：574-581.
[20] Nakamura N，Obayashi H，Fujii M，et al.Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end products.Free Radic Biol Med，2000，29(1)：17-25.
[21] Derubertis F，Rcraven PA.Activation of protein kinase C in glomerular cells in diabetes.Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy.Diabetes，1994，43(1)：1-8.
[22] Heidland A，Sebekova K，Schinzel R.Advanced glycation end products and the progressive course of renal disease.Am J Kidney Dis，2001，38[4 Suppl 1]：100-106.
[23] Wang H，Deng H，Liu W.The effects of paraoxonase-1 and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus.Zhonghua Nei Ke Za Zhi，2002，41(3)：179-182.
[24] Korshunov SS，Skulachev VP，Starkov AA.High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria.FEBS Lett，1997，416(1)：15-18., 百拇医药(苏 毅)
[17] 刘志红.胰岛素抵抗在糖尿病肾病发病中的作用.中国实用内科杂志，2002，22(9)：519-521.
[18] Venable ME，Zimmerman GA，McIntyre TM，et al.Platelet-activating factor：a phospholipid autacoid with diverse action.J Lipid Res，1993，34(5)：691-702.
[19] Lenz O，SJ，Stetler-Stevenson WG.Matrix metalloproteinases in renal development and disease.J Am Soc Nephrol，2000，11(3)：574-581.
[20] Nakamura N，Obayashi H，Fujii M，et al.Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end products.Free Radic Biol Med，2000，29(1)：17-25.
[21] Derubertis F，Rcraven PA.Activation of protein kinase C in glomerular cells in diabetes.Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy.Diabetes，1994，43(1)：1-8.
[22] Heidland A，Sebekova K，Schinzel R.Advanced glycation end products and the progressive course of renal disease.Am J Kidney Dis，2001，38[4 Suppl 1]：100-106.
[23] Wang H，Deng H，Liu W.The effects of paraoxonase-1 and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus.Zhonghua Nei Ke Za Zhi，2002，41(3)：179-182.
[24] Korshunov SS，Skulachev VP，Starkov AA.High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria.FEBS Lett，1997，416(1)：15-18., 百拇医药(苏 毅)